TOI
Oncology Institute, Inc. · Healthcare
Insiders bought $333K net in the last 90 days ·1 seller, 1 buyer· 1 of 2 sales under Rule 10b5-1 plans· latest Form 4 filed Jul 22, 2026
Insider Buying
$2.6M
reported purchases (SEC code P)
Insider Selling
$863K
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Jul 29, 2026
Chernett Jorey
Oncology Institute, Inc. (TOI) has 52 SEC Form 4 filings (73 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jul 29, 2026.
Inside the rolling window, 6 insiders at Oncology Institute, Inc. reported 14 open-market purchases totaling $2.6M and 7 open-market sales totaling $863K. The most active filer is 10% Owner Chernett Jorey with 14 filings. Insiders have net bought $2.0M over the trailing 6 months. The most recent open-market filing is a purchase of 18,000 shares by 10% Owner Chernett Jorey, dated Jul 21, 2026, worth $95K.
- Industry:Medical - Care Facilities
- CEO:Daniel Virnich
- Employees:641
- HQ:Cerritos, CA, US
- IPO:2020-06-04
| Source | |||||||
|---|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 18,000 | $95K | Jul 22 | +17.2% | SEC ↗ | |
| Chief Medical Officer | Sale | 23,452 | $150K | Jul 17 | +15.7% | SEC ↗ | |
| 10% Owner | Purchase | 15,000 | $88K | Jul 13 | -0.8% | SEC ↗ | |
| 10% Owner | Purchase | 18,000 | $90K | Jun 24 | +18.1% | SEC ↗ | |
Podnos YaleFirst filing | Chief Medical Officer | Sale | 23,451 | $126K | Jun 9 | +25.0% | SEC ↗ |
| 10% Owner | Purchase | 12,000 | $57K | Jun 5 | +27.3% | SEC ↗ | |
| 10% Owner | Purchase | 35,000 | $143K | May 21 | +38.7% | SEC ↗ | |
| 10% Owner | Purchase | 33,500 | $136K | May 21 | +38.7% | SEC ↗ | |
Kaushal MohitFirst filing | Director | Sale | 57,286 | $201K | Apr 16 | — | SEC ↗ |
Kaushal MohitFirst filing | Director | Sale | 38,433 | $135K | Apr 16 | — | SEC ↗ |
| 10% Owner | Purchase | 20,000 | $62K | Apr 13 | — | SEC ↗ | |
| 10% Owner | Purchase | 27,429 | $81K | Mar 30 | — | SEC ↗ | |
| 10% Owner | Purchase | 50,000 | $158K | Mar 27 | — | SEC ↗ | |
| 10% Owner | Purchase | 125,000 | $389K | Mar 25 | — | SEC ↗ | |
| 10% Owner | Purchase | 25,000 | $84K | Mar 23 | — | SEC ↗ | |
| 10% Owner | Purchase | 263,000 | $768K | Mar 17 | — | SEC ↗ | |
| 10% Owner | Purchase | 60,985 | $201K | Mar 17 | — | SEC ↗ | |
| 10% Owner | Purchase | 75,000 | $257K | Mar 17 | — | SEC ↗ | |
Carter Robert RossFirst filing | Chief Financial Officer | Sale | 247 | $879 | Jan 5 | — | SEC ↗ |
Hively BradFirst filing | Director | Sale | 13,333 | $50K | Dec 16 | — | SEC ↗ |
Pacala Mark LFirst filing | Director | Sale | 50,000 | $200K | Nov 20 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does TOI have?
Oncology Institute, Inc. (TOI) has 52 SEC Form 4 filings (73 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Jul 29, 2026.
When was the most recent SEC Form 4 filing for TOI?
The most recent Form 4 filing for TOI on Tracefour is dated Jul 29, 2026.
Who is the most active insider at TOI?
The most active SEC Form 4 filer at TOI in the rolling window is 10% Owner Chernett Jorey, with 14 filings.
What is the net insider flow at TOI over the last 6 months?
Over the trailing 180 days, insiders at TOI have net bought $2.0M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at TOI in the current window?
Inside the rolling window, insiders at TOI bought $2.6M and sold $863K based on SEC Form 4 filings.
Can I get alerts for TOI insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Oncology Institute, Inc. (TOI). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Oncology Institute, Inc. is in the Healthcare sector.